Agency and distribution partership for branded medicines in China
Farmavita.Net member is looking for long-term agency and distribution partership of branded anticancer or cardiovascular medicines in China. Neptunus Group was established in 1989, and now it has been one of the famous brands of the health industry in China, the comprehensive competitiveness of which ranks the top in the pharmaceutical industry in China.
Synergistic formulation of antioxidants and antimycobacterial agents
The present invention pertains to a six compound pharmaceutical formulation and its process of making comprising of antituberculosis agents like Rifampicin, Isoniazid, Pyrazinamide, and Ethambutal with addition of antioxidants such as d-alpha tocopherol or tocopheryl acetate and pharmaceutically accepted salts thereof and ascorbic acid in required therapeutic quantities for use in treatment of tuberculosis in mammals. This six drug formulation shows synergistic mycobactericidal activity coming along with reduction in oxidative stress, leading to reduction in lung cell damages. The present invention further demonstrates mycobactericidal activity of antioxidants such as d-alpha tocopherol and tocopheryl acetate.
Farmavita.Net member is looking for tacrolimus hard capsules with the BE study matching narrow limits both for the AUC and Cmax (90-111%), fed and fasted.
Farmavita.Net member take this opportunity to
introduce themselves as one of the fastest growing pharmaceutical company from
Looking for KETOPROFEN 25, 50, 75, 100, 150, and 200 mg capsules
Registered user of Farmavita.Net is looking for EU CTD Dossier with supply for KETOPROFEN 25, 50, 75, 100, 150, and 200 mg capsules.
Demand: In-vitro Models of Ginival Tissue
The "TOP 10 Global Pharma Company" is seeking:
Novel in vitro models that mimic oral gingival tissue
They are looking for potential partners with unique innovative technologies to meet changing needs of global consumers. Seeker is the leading research-based pharmaceutical and healthcare company in the world, employing 100,000+ people in 100+ countries.
Pharmaceutical companies will use virtual R&D to increase innovation and reduce commercial deficit
By 2020 the Pharma R&D process may be shortened by two-thirds,
success rates may dramatically increase, and clinical trial costs could
be cut substantially, according to research launched today by
PricewaterhouseCoopers, entitled Pharma 2020: Virtual R&D, which path will you take? New
computer based technologies will create a greater understanding of the
biology of disease and the evolution of ‘Virtual man’ to enable
researchers to predict the effects of new drug candidates before they
enter human beings. Along with changes underway in the regulatory and
socio-political environment, this will enable Pharma to overcome one of
the most fundamental issues it needs to resolve over the next decade.
MALARIA: AN OVERVIEW WITH HERBAL TREATMENT
The success of the antimalarial drug quinine and the discovery of artemisinin, the most potent antimalarial drug, both from plant sources, has led to the study of plants as antimalarial agents. The ethnopharmacological approach for the search of new antimalarial agents from plant sources has proved to be more predictive. In India the National Malaria Eradication Programme (NMEP), started in 1958, achieved near complete disappearance of the disease in 1960s.
The whole 34 pages article is available for download at Downloads section of Faramavita.Net
2nd Annual
Observational Research to Demonstrate Drug Safety
Bratislava, Slovakia, October 22-23, 2009.
This event will be examining the growing role of non-interventional research in achieving stronger safety results, and higher drug performance. Focusing on the methodological and operational aspects delegates will be exposed to some of the most cutting-edge case studies in the area.
Market leaders and non-pharma stakeholders will present their latest views on: How to design a study, what type of studies have been successful, how to demonstrate clinical data accuracy, what is the future of observational research standardisation and the role of ethics committees.
Pricing and Reimbursement in Key Asia Pacific Markets
With the Asia-Pacific markets growing rapidly, they are becoming increasingly attractive for Pharma to enter. However, a number of key P&R developments and reforms are set to change the healthcare environment in the next few years, as healthcare is made more accessible to the poor and elderly.
- Networking Tips & Tricks
Monitoring news at Farmavita.Net
You can easily monitor all new articles published at Farmavita.Net . Click on the RSS button and bookmark the main RSS feed of Farmavita.Net. RSS button is located in URL field of your browser and also at the lower right side of every Farmavita.Net page
- Latest Published
- Site Sections
- Popular Pages
3D Content Cloud
Login to Farmavita.Net
BabelFish Translator
Click Flag for Translation
Who's Online
Farmavita.Net RSS News
